HOME >> BIOLOGY >> NEWS
Audience pick: Older violin, sweeter music?

lections of Nagyvary's choosing will be played by Regina Buonavenura from Manilla, The Philippines, in honor of Nagyvary's retirement. Nagyvary enlisted Bounavenura, who owns a violin made by him, to play his own 10-year-old violin.

The scientist said he will consider the comparison concert a success if as many as 40 percent pick his violin as the Stradivarius.

Nagyvary, who in the 1980s began using his knowledge of biochemistry to study the intricacies of the famous violins made in the 18th century by Antonio Stradivari, is not one to duck a challenge. Under the sponsorship of the American Chemical Society two years ago, one of his violins was pitted against an average Stradivarius (some 700 still exist) for a comparison test. Critics at that time could not tell the violins apart, Nagyvary said, though some reported they could detect a slight difference. A CD recording of that event is available for $14 by calling 800-523-5184, Nagyvary said.

This comparison concert will be different for several reasons: the ultimate of Stradivari violins - the $4 million Rochester - will go up for the test; the audience will get to decide which sounds better; and, a film crew will get footage for an upcoming film about Antonio Stradivari that will be broadcast around the world.

To prepare for the event, Nagyvary whipped out a new violin in a record six weeks, allowing that 300-year-old maple from the Himalayan mountains in China had been prepared some six months ago. With the violin fully assembled in mid-July, Nagyvary began vibrating the violin - mostly mechanically - to condition it for playing. A violin has to be played in tune -- every position and every note with the scales and ambitious music -- to be balanced, Nagyvary explained.

"I'm even attempting to fake the age so that even if the screen were removed, the audience would not be able to tell the two violins apart," Nagyvary said.

The
'"/>

Contact: Kathleen Phillips
ka-phillips@tamu.edu
979-845-2872
Texas A&M University - Agricultural Communications
26-Aug-2003


Page: 1 2 3

Related biology news :

1. "Health Of Hanford" Conference Gathers Diverse Audience To Review And Discuss Health Issues
2. Older drug could have exciting new role in treating colorectal cancer
3. Older pilots OK to fly, study shows
4. Older adults can exercise just once a week to maintain muscle strength
5. Older fathers more likely to have children with schizophrenia
6. Older fathers substantially raise the risk of having children with schizophrenia
7. Vitamin D Deficiency May Increase Risk Of Hip Fracture In Older Women
8. PSA Levels Mean More Extensive Prostate Disease In Older Men
9. Florida Or Bust? Older Lab Rats Seek Heat To Fight Infection, UD Researchers Report
10. American Heart Association Comment: Sodium Reduction And Weight Loss In The Treatment Of Hypertension In Older Persons
11. Long-Term Vitamin C Use Cuts Cataract Risk In Older Women

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Audience pick Older violin sweeter music

(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:7/2/2015)... 2015 Research and ... the "Natural Language Processing Market by Type ... Pattern & Image Recognition) - Worldwide Forecast to ... The key vendors occupying the market are 3M, ... Corporation, NetBase Solutions, SAS Institute Inc., Verint Systems ...
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
(Date:7/30/2015)... ... , ... Ralco is honored to announce that it is the primary sponsor ... August 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience where the ... their daily lives. This unique exhibit also features a birthing center for fair goers ...
(Date:7/30/2015)... July 30, 2015 According to ... (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, ... Preclinical, Clinical Trial), by End Users - Global Forecast ... expected to reach USD 2,107.99 million by 2020 from ... 15.29%. Browse more than ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: